Sumitomo Dainippon

Sumitomo Dainippon Pharma Co., Ltd. is a pharmaceutical company formed in 2005 by the merger of Sumitomo Pharmaceuticals Co., Ltd. and Dainippon Pharmaceutical Co., Ltd. Headquartered in Chuo-ku, Osaka, Japan, the company specializes in multiple business segments, including prescription and over-the-counter medications, psychiatric and neurological pharmaceuticals, oncology, and regenerative medicine/cell therapy. Additionally, the company has a significant presence in the international pharmaceutical market, notably through its subsidiaries. Sunovion Pharmaceuticals Inc., a United States-based firm, is recognized for its work in psychiatric and neurological medications. Moreover, Boston Biomedical Inc. is a subsidiary that focuses on oncology. Sumitomo Dainippon Pharma and its associated brands have crucial markets in Japan, the United States, and other parts of the world, and maintain a global presence across North America, Europe, and Asia. (Powered by AI)